Order from our trusted online pharmacy and get affordable prescription drugs with no compromise on quality.
Empagliflozin (brand name of Jardiance) can help people experience modest weight loss by helping kidneys excrete excess glucose in urine, and thus calories.
The weight loss in clinical trials for type 2 diabetes is reported to reach approximately 2–3 kg in adults taking this medicine in some months use.
Note that the results depend on patients' blood sugar levels, kidneys, lifestyle, use of other drugs, and other factors. This drug can be prescribed by doctors to address several diseases, including diabetes, but not particularly for inducing weight loss.

Empagliflozin weight loss and Jardiance weight loss are generally modest effects that may occur during treatment for approved medical conditions rather than the primary purpose of taking the medication.
So, if you began taking Jardiance recently, it is possible that the scale readings start to fluctuate gradually.
Initially, the slight weight loss can be caused by getting rid of the excess fluid in patients' bodies, while later the weight loss is possible due to the fat removal.
Let us learn how the drug causes weight loss in patients with type 2 diabetes.
Empagliflozin is classified as a drug that falls into the SGLT2 (sodium-glucose co-transporter-2) inhibitor category.
Under usual circumstances, the kidneys help the patient's body reabsorb much of the glucose from blood. Empagliflozin inhibits the absorption in some cases, which results in additional elimination of glucose via the urine.
Due to the presence of calories in the substance, removing glucose through urine implies eliminating energy that the body could use further.
These factors explain how this drug helps with weight loss.
For people asking how does empagliflozin help with weight loss, its main mechanism involves removing some glucose and associated calories through urine, which may contribute to modest weight reduction.
Besides that, the drug promotes the increase of urine production. That explains why some patients may initially lose weight because their bodies lose the excess fluid.
In the long run, the calorie loss helps promote weight loss by modest reduction of the body fat of some people. However, the effects of empagliflozin on the patients' appetites are not comparable with those of weight-loss treatments.
In general, the drug's weight-loss properties make it less efficient than other medications specially developed for weight loss management.
The question how much weight can you lose with empagliflozin depends on factors such as blood glucose levels, kidney function, diet, activity, and individual response.
Average Weight Loss Demonstrated During Clinical Trials
According to the information published by the FDA, clinical trials showed that there were body weight reductions among people having type 2 diabetes and using this drug.
For patients asking what is the average weight loss with Jardiance, clinical trial findings describe modest average reductions over several months rather than a guaranteed amount for every patient.
The percentage of body weight that was reduced in patients using the drug alone during 24 weeks' time was approximately 2.8% for 10-mg doses of empagliflozin and 3.2% – in the case of 25-mg dose of the drug.
If we assume that patients had an average weight of approximately 78 kg in the course of the clinical trial, this percentage refers to 2.2-2.5 kg of weight loss.
Another weight reduction of 2-3 kg over several months is demonstrated in clinical trials.
Such findings explain why Jardiance weight loss is considered modest compared with other medicines.
These Empagliflozin weight loss results describe average outcomes observed in specific studies and should not be interpreted as predictions for individual patients.
Still, the results of clinical trials cannot be considered guarantees. Some patients can lose more weight or almost nothing.
Yes. Jardiance 10 mg weight loss has been observed by clinical trials.
Usually, the 10-mg dose of this medicine is prescribed as a standard dose of the drug for patients with type 2 diabetes. This dose is recommended for other treatment indication. Patients are likely to start to lose weight gradually due to the medication that makes the patient get rid of excess glucose.
But not all patients who use empagliflozin 10 mg lose significant amount of weight.
Their glucose levels, kidney function, food consumption, and other drugs used can be responsible for this effect.
Weight reduction in patients taking the 25-mg dose of empagliflozin is likely to be slightly higher. But the difference may not be considerable in some cases.
The Empagliflozin 25 mg weight loss reported in clinical studies may be slightly greater than with 10 mg, but the difference does not mean that a higher dose is suitable for weight management.
For example, the previously mentioned clinical trial that showed the average percentage of 2.8% weight reduction in the case of 10-mg dose demonstrates approximately 3.2% weight reduction in case of 25-mg dose after 24 weeks of the treatment.
But the increased dosage of this medication doesn't multiply the weight loss by two.
For patients wondering does Jardiance 10 mg or 25 mg cause more weight loss, the higher dose may produce a slightly greater average reduction in some studies, but treatment decisions should be based on medical indications and tolerability.
Doctors can increase dosage of this drug from 10 mg to 25 mg if additional glucose regulation is required. But you should never do that simply to lose more weight. Such dosages can be no more effective when it comes to weight loss.
It takes various amounts of time for patients taking this drug to lose weight. But the changes of the weight reading aren't always connected to the changes in patients' body fats.
The Empagliflozin weight loss timeline can include early fluid-related changes followed by more gradual changes in body weight over the following months.
Empagliflozin starts promoting glucose excretion from patients' bodies right after the treatment was introduced.
It can lead to the increase of urination frequency in patients, which can promote some initial weight loss.
But it is too early to expect losing some fat in the course of the very initial days.
So, the lack of change during the first several weeks does not mean that empagliflozin didn't start producing its weight-loss effects.
Weight loss may become noticeable after the first one-two-three months of using the medication.
With every week, there is glucose elimination through urine, which can lead to the reduction of weight.
Patients can feel how their clothes became looser, as well as observe some trends on the scale.
For people researching Empagliflozin weight loss per month, there is no reliable monthly amount that applies to everyone because weight changes vary with treatment response and other factors.
But there isn't the reliable amount of Jardiance weight loss per month that is applicable to all patients.
Clinical trials demonstrate changes in patients over a long-term treatment rather than show the expected changes per month.
By three to six months, the treatment becomes quite enough for patients to see whether the drug has influenced their weight readings.
The average weight reduction was demonstrated in clinical trials where the medication was used for 24 weeks of the treatment.
But the weight loss in patients can become slower or stop after some time.
The human body can adapt to changes in calorie balance. And food consumption or other medications can influence further weight loss.
For patients asking how long does Jardiance take to cause weight loss, some changes may appear within weeks, while more noticeable trends can develop over one to three months or longer.
No. Weight loss is not experienced by every person using the drug.
Despite the fact that people take the same dose of the medicine, their weight changes can be different. Several factors influence weight loss with this drug:
Starting weight: weight may affect how weight loss changes are seen on the scale.
Blood glucose levels: higher glucose levels affect how much glucose is removed in the form of urine.
Eating habits: patients' food consumption affects weight loss.
Physical activity: this factor is beneficial for weight management and overall health.
Kidney function: the drug reduces the glucose level in the patients' body partially due to kidney function.
Other medications: insulin and sulfonylureas can increase the chances of weight gain in some patients.
Treatment duration: weight changes occur gradually.
Weight loss with Jardiance weight loss before and after comparisons in other patients cannot be the best way to predict your own experience.
The doctors consider blood glucose, patients' cardiovascular and kidney functions, and other treatment purposes rather than just weight.
No. Empagliflozin is not an FDA-approved medication that is designed specially to manage weight loss.
Its applications are focused on diabetes treatment and reduction of cardiovascular and kidney risks.
Empagliflozin reduces patients' blood glucose level by helping to excrete excess glucose in urine. In case of proper usage, this drug can promote better blood glucose control in patients with type 2 diabetes along with healthy diet and physical activity.
Modest weight loss can be observed additionally.
For patients asking does empagliflozin cause weight loss in people with diabetes, clinical trials involving adults with type 2 diabetes have shown modest average reductions, although not everyone loses weight.
But reducing blood glucose level and managing overall diabetes condition is still a more important goal than any other effect.
Empagliflozin is also used to reduce risks associated with cardiovascular mortality and the risk of hospitalization because of heart failure. This benefit doesn't depend on reaching any particular amount of weight loss.
Patients with heart failure may experience weight loss as a consequence of fluid balance in the body.
Sometimes the quick weight increase or decrease can be related to some changes in fluid balance rather than body fat. If you take the drug in order to manage heart failure, you should follow the instructions of your healthcare provider on monitoring your weight and daily fluid balance.
The prescription of this medicine for certain patients with chronic kidney disease helps to reduce the risk of disease progression and cardiovascular complications. This benefit of the drug is unrelated to its weight-loss effect.
Decisions about prescription and treatment of patients with kidney disease depend on kidney function, general health state of patients, and other conditions.
Although this drug can cause weight loss in patients with type 2 diabetes, its average weight reduction effect is modest compared to other treatments.
Drugs specifically prescribed to treat chronic weight problems act through other principles and produce larger average weight loss effect.
Empagliflozin should not be taken to achieve cosmetic weight reduction effects.
Various diabetes medications affect the body weight of patients in different ways. Empagliflozin (Jardiance) commonly promotes modest weight loss by increasing glucose and calories elimination through urine.
The effects of metformin on patients' weights are neutral in general. Some patients lose modest weight while taking the medication. Semaglutide (Ozempic) can also produce greater average weight reduction in certain patients compared with empagliflozin.
Still, Ozempic is designed to meet a set of FDA indications and has different dosages from other semaglutide products. Tirzepatide (Mounjaro) is another drug that may cause weight loss for patients with type 2 diabetes. However, its weight-loss effect depends on its dose and the patients' reaction to it.
Insulin leads to the weight gain due to promoting reduction of glucose and calories removal through urine. Sulfonylureas (for instance, glipizide) may cause weight gain due to increasing the insulin level.
These drugs shouldn't be chosen according to weight changes they cause.
Doctors must also consider patients' blood glucose, heart, and kidneys, the risks of hypoglycemia, and other aspects while selecting the diabetes medication.
Patients using Jardiance can adopt certain practices to promote proper treatment and healthy weight management.
These approaches include:
Eating healthy meals: vegetables, fibre, moderate carbohydrates, protein are recommended.
Staying physically active: walking, and other exercises can help promote patients' weight management.
Maintaining fluid intake: following the recommendations of your physician regarding this issue.
Monitoring weight changes: observing changes in patients' weight in several weeks rather than in the daily basis.
Following your prescription: taking empagliflozin regularly in the prescribed dosage.
Avoiding extreme diets: ketoacidosis may be caused by such diets and fasting for too long.
If you are prescribed empagliflozin due to heart failure or kidneys disease, you have different fluid and dieting requirements from those who take it only for diabetes.
Therefore, you should ask your physician for advice in advance before changing your eating practices.
Empagliflozin promotes weight loss in patients by increasing elimination of glucose and fluid in urine. Although these processes can be helpful for weight management, this drug can also cause dehydration or low blood pressure in some patients.
Increased fluid loss can be caused by increased urination.
It can result in dizziness, lightheadedness, and weakening feelings when standing. These problems may be more pronounced in elderly, patients with impaired kidney function, and patients who are taking diuretics.
If you experience unusual thirst, dizziness, and faintness, you should tell this to your healthcare provider immediately.
.webp)
Rapid weight loss should not be associated with empagliflozin automatically. This symptom may reflect dehydration, poor diabetes treatment, some other disease, or fluid loss. Unexplained weight loss accompanied by exhaustion, vomiting, and reduced food consumption should require medical assistance. Don't neglect these symptoms just because the weight loss effect is known in case of empagliflozin usage.
Diabetic ketoacidosis is the one serious side effect of this medication.
It is associated with dangerous levels of some acids (ketones) in the bloodstream.
Even if the level of glucose in blood isn't really high, ketoacidosis can occur.
If such ketoacidosis symptoms appear, stop taking this drug immediately and consult your healthcare provider.
Empagliflozin also increases risks of some genital fungal infection and urinary tract infections.
Such symptoms as painful urination, fever, and genital irritation should be told to your doctor. Pain, swelling, fever, and redness in the area of genitals and perineum require immediate examination because of the possibility of serious infections.
According to the FDA prescribing information, you should withhold the use of empagliflozin for at least three days prior to any planned surgeries, if it is possible.
Your doctor may recommend you to temporarily withhold this drug in case of some severe illness, prolonged fasting, and dehydration. Follow sick-day instructions given by your doctor, rather than withhold this medication on your own.
Lack of changes on the scale can be discouraging because of Jardiance weight loss, which some other patients experience. Still, weight reduction cannot be expected for this treatment.
Empagliflozin provides smaller average weight changes compared to those of drugs specifically used for treating weight problems.
Loss of several pounds of body weight over several months is hard to notice in particular. In addition, not all patients lose some weight during the treatment.
Some other medications, food consumption, activity level, and underlying health conditions may influence body weight of patients.
For instance, some other diabetes medications such as insulin may cause weight gain.
Fluid retention can mask the changes in body fat.
The patients' weight remains constant even while improving the blood glucose control.
If you use this medication for treating type 2 diabetes, the doctor will probably check the glucose readings and HbA1c level. For heart failure and chronic kidney disease, the treatment success involves other factors.
If you are worried about changes of your weight, then you should ask your doctor whether this phenomenon is expected to happen and whether there is need for further examination. Don't increase your dose simply because you haven't lost weight yet.
How much weight can you lose on Jardiance in a month?
There is no fixed amount of weight per month of the treatment that would apply to everybody. In some cases, the minor weight loss is experienced during the first month partially due to fluid loss. Clinical trials demonstrate modest weight reductions over several months.
How long does it take to lose weight on empagliflozin?
Some initial changes can happen during the first several weeks, while noticeable changes can become evident in one-two-three months. Clinical studies have shown modest average reductions during approximately 24 weeks' treatment.
Does empagliflozin 10 mg cause weight loss?
Yes. 10-mg dose of this drug can cause modest weight loss in patients having type 2 diabetes. But results may vary, and the medication is not prescribed specifically for this purpose.
Can empagliflozin help lose belly fat?
Empagliflozin can contribute to body fat loss in general. But it doesn't reduce only the abdominal fat.
Does empagliflozin reduce appetite?
Empagliflozin is not an appetite suppressant. The effects of the medication imply promoting excretion of glucose in urine, not influencing on appetite. Some patients may notice some changes, but they are not the major ones.
Can you lose 10 pounds while taking Jardiance?
Yes, patients may lose 10 pounds, but this effect is larger than average weight losses reported by several clinical trials.
Does empagliflozin make patients lose weight without exercise?
Some people lose weight taking empagliflozin even without additional exercise because of the effects on calorie balance of the body. But physical activity is beneficial in terms of overall diabetes management and weight management.
Is the effect of this drug permanent?
The weight loss is not necessarily permanent. The changes can stabilize and continue after the use of this drug stops. Following healthy nutrition practices and exercising can help manage your weight in the long-term period.
Can people without diabetes use this drug to lose weight?
Empagliflozin is not designed to be used as weight loss treatment in the patients without diabetes. But some patients eligible for this disease-free indication can be prescribed this drug. Use as a weight loss aid is not FDA-approved.
Weight loss with empagliflozin happens as it assists the body in excreting excess blood glucose.
Research involving adults with type 2 diabetes has documented the elimination of 2–3 kg of weight in months.
In some cases, the effect can be due to dehydration, but in other cases, weight loss will occur due to fat reduction.
However, Jardiance is not meant specifically for weight loss. Instead, the advantages of the drug relate to its officially recognized indications, which include diabetes management, heart failure, and kidney problems.
Pay attention to treatment purposes rather than fast-scale results.
Use the drug as prescribed, consult on nutrition and hydration, and visit doctors regularly.
Discuss any unexpected weight loss, dehydration issues, drug timing, and adverse effects with your healthcare provider or a Grant Pharmacy specialist to ensure safe use of the drug.